A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia. Prebet T, Goldberg AD, Jurcic JG, Khaled S, et al. Leuk Lymphoma 2022 May 1:1-9. doi: 10.1080/10428194.2022.2057484.

Read + Share

Amedeo Smart

Independent Medical Education

Prebet T, Goldberg AD, Jurcic JG, Khaled S, et al. A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia. Leuk Lymphoma 2022 May 1:1-9. doi: 10.1080/10428194.2022.2057484.
PMID: 35491816